STARR CHRISTOPHER M

Insider profile

Performance

Overall performance
1.4

Performance over holding periods
1.4
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
STARR CHRISTOPHER M's trades of Monopar Therapeutics Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
40.00
Quantity 16,800
Value US$672,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-05 2026-10-01 PlS Planned sale
70,737 -44.3%
330.05
US$3,076,917
70,737 -44.3% 330.05 US$3,076,917
2026-10-05 2026-10-01 PlS Planned sale
29,143 -3.3%
145.59
US$1,949,139
29,143 -3.3% 145.59 US$1,949,139
2026-10-05 2026-10-01 PlS Planned sale
77,038 +24.3%
327.19
US$2,111,952
77,038 +24.3% 327.19 US$2,111,952
2026-10-01 2026-10-01 PrS Proposed sale
16,800
79.67
US$1,338,456
16,800 79.67 US$1,338,456
2025-07-16 2025-07-14 S Sale
16,800 -76.5%
40.00
US$672,020
16,800 -76.5% 40.00 US$672,020
2025-07-14 2025-07-14 PrS Proposed sale
16,800
40.00
US$672,000
16,800 40.00 US$672,000